On November 19, 2020, the U.S. Department of Justice announced that it had entered into settlement agreements with a Johnson & Johnson subsidiary and a private equity firm, the Gores Group. The settlement with TGG related to alleged False Claims Act violations by a former TGG portfolio company. This settlement is the latest indication of a continuing trend in FCA enforcement actions against private equity firms. It underscores for private equity firms the need to assess the heightened risk of FCA liability in connection with portfolio companies operating in certain industries where FCA claims are more likely, such as in the health care and life sciences space, to incorporate such assessments into their diligence process for new acquisitions, and to consider carefully their level of involvement in the operations of portfolio companies particularly in these industries.
Regulations, Compliance, & Enforcement
Trending Now
SBIR/STTR Reauthorization Brings New Opportunities and New Diligence Expectations • DOJ Announces Initiative for Data Miners Filing Qui Tam Complaints • FAR Overhaul Continues: Government Doubles Down on DEI Enforcement with New Clause and Debarment Risk • Ninth Circuit Rejects Use of Lodestar Multiplier in Determining Reasonable Attorneys’ Fees Despite Counsel’s “Herculean Efforts” • Third-Party AI Risk and Vendor Due Diligence
DOJ Settles Claims with Private Equity Firm over Alleged False Claims Act Violations by Its Portfolio Company
Artur Szczybylo | Shutterstock
Track False Claims Act cases, audit trends, and compliance best practices with our Compliance & Enforcement newsletter, delivering up-to-the-minute intelligence Monday–Saturday — Subscribe here.